| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $11.5M | +33.7% |
| SG&A Expense | $12.3M | +12.1% |
| Operating Income | -$23.8M | -21.6% |
| Net Income | -$23.7M | -21.2% |
| EPS (Basic) | -$0.50 | -13.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $35K | — |
| Current Assets | $21.5M | -45.1% |
| Total Assets | $25.1M | -41.5% |
| Current Liabilities | $2.8M | +77.3% |
| Total Liabilities | $2.5M | +55.0% |
| Stockholders' Equity | $22.3M | -46.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.8M | -24.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $98K | +216.6% |
| Financing Cash Flow | $6K | -100.0% |
| Free Cash Flow | -$17.8M | -24.2% |